NIPPON SHINYAKU CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,073 JPY | +5.98% |
|
-12.65% | -38.49% |
| Apr. 10 | Jefferies Adjusts Nippon Shinyaku’s Price Target to 5,100 Yen From 6,900 Yen, Keeps at Buy | MT |
| Mar. 18 | Nippon Shinyaku Co., Ltd.(TSE:4516) dropped from S&P Japan Mid Cap 100 | CI |
| Sales 2024 | 148B 942M | Sales 2025 * | 152B 965M | Capitalization | 207B 1.31B |
|---|---|---|---|---|---|
| Net income 2024 | 25.85B 164M | Net income 2025 * | 26.14B 166M | EV / Sales 2024 | 1.59 x |
| Net cash position 2024 | 65.83B 418M | Net cash position 2025 * | 83.74B 532M | EV / Sales 2025 * | 0.81 x |
| P/E ratio 2024 |
11.6
x | P/E ratio 2025 * |
8.01
x | Employees | 2,186 |
| Yield 2024 |
2.77% | Yield 2025 * |
4.12% | Free-Float | 90.75% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | +5.98% | ||
| 1 week | -12.65% | ||
| 1 month | -29.58% | ||
| 3 months | -35.58% | ||
| 6 months | -42.36% | ||
| Current year | -38.49% |
1 week
2 694.00
3 574.00
1 month
2 694.004 475.00
Current year
2 694.005 330.00
1 year
2 694.006 784.00
3 years
2 694.009 840.00
5 years
2 694.0010 360.00
10 years
1 945.0010 360.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hideyuki Fujii
DFI | Director of Finance/CFO | - | - |
Toru Nakai
PSD | President | 52 | 95-03-31 |
| Chairman | 71 | 76-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 76-03-31 | |
Shouzou Sano
BRD | Director/Board Member | 63 | 84-03-31 |
Takashi Takaya
CMP | Compliance Officer | 63 | 84-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.88% | 19 M€ | +11.22% | ||
| 0.23% | 57 M€ | +19.30% | ||
| 0.23% | 240 M€ | +17.47% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 3,073 | +5.98% | 1,280,500 |
| 24-05-30 | 2,900 | +3.96% | 1,701,300 |
| 24-05-29 | 2,789 | -2.96% | 3,106,700 |
| 24-05-28 | 2,874 | -19.59% | 337,500 |
| 24-05-27 | 3,574 | +1.59% | 279,000 |
Delayed Quote Japan Exchange, May 31, 2024 at 02:00 am EDT
More quotes
Nippon Shinyaku Co., Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceutical products and functional foodstuffs. The Company operates in two business segments. The Pharmaceutical segment is involved in the manufacture and sale of urinary system therapeutic agents, blood cancer therapeutic agents, pain, inflammation and allergic therapeutic agents, digestive system therapeutic agents, cardiovascular systems and metabolic therapeutic agents. The Functional Foodstuff segment involves in the manufacture and sale of health food materials, quality stability preservatives, protein preparation, spice and seasoning products. The Company is also involved in the business support business, non-life insurance agency business, as well as the provision of real estate leasing services.
Sector
Pharmaceuticals
Calendar
2024-08-05
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
3,073
JPY
Average target price
5,064
JPY
Spread / Average Target
+64.80%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -38.49% | 1.32B | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- 4516 Stock
